Abbott Laboratories (ABT)

Subsidiaries

Cardiovascular Systems, Inc.

Number of Facilities: 5

* Abbott Laboratories has disclosed their China operations data.

Total Estimated Sanctions (3-year Avg.)

$528,587,476

Average Annual Revenue

Global

$36,279,666,667

China Revenue

5.89%

$2,136,333,333

Annual Average of Total Assets

Global

$71,386,333,333

China Assets

5.99%

$4,277,723,590

Facilities & Trade in China

Total Export Dollars

$10,105,762

Ports of Exit

5
Annual Revenue
201820202022
Global Data$30,578,000,000$34,608,000,000$43,653,000,000
China Data$2,311,000,000$1,965,000,000$2,133,000,000
Operating Expense
201820202022
Global Data$14,222,000,000$14,248,000,000$16,149,000,000
China Data$1,074,859,114$808,984,050$789,082,469
Total Assets
201820202022
Global Data$67,173,000,000$72,548,000,000$74,438,000,000
China Data$5,076,748,087$4,119,186,893$3,637,235,791
Cost of Goods Sold for Chinese Activity
201820202022
Global Data$12,706,000,000$15,003,000,000$19,142,000,000
China Data$960,284,060$851,852,028$935,328,294
Operating Profits / Total Assets
201820202022
Global Data5.43%7.38%11.23%
China Data5.43%7.38%11.23%
Operating Profits
201820202022
Global Data$3,650,000,000$5,357,000,000$8,362,000,000
China Data$275,856,825$304,163,922$408,589,238
Generate Reports
Clear
Toast